Current stock page

Financial Data

INVA Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

INVAInnoviva, Inc.

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 8/10
$19.03+$0.06 (+0.32%)

Latest quote

  • Momentum
    43
  • Value
    92
  • Quality
    76
  • Risk resilience
    74
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$106.12M$119.59M$97.99M$118.05M$107.8M$100.28M$88.63M$91.81M
Gross Profit$84.38M$90.62M$75.83M$75.61M$82.02M$89.69M$79.79M$84.64M
Operating Income$42.15M$50.86M$38.15M$38.99M$34.58M-$48.75M-$41.43M$43.14M
Net Income-$73.89M-$83.42M$186.6M$164.15M$89.91M$63.69M-$46.58M$20.33M
EPS-$1.03-$1.14$2.52$2.19$1.3$1.01-$0.74$0.32
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow$41.7M$51.97M$35.28M$54.51M$49.73M$44.07M$48.62M$59.24M
Capital Expenditure-$24K-$429K-$492K-$1.13M-$1.12M$0$0-$4M
Free Cash Flow$41.67M$51.54M$34.79M$53.38M$48.61M$44.07M$48.62M$55.24M
Net Cash Provided By Operating Activities$41.7M$51.97M$35.28M$54.51M$49.73M$44.07M$48.62M$59.24M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$1.54B$1.7B$1.84B$1.64B$1.43B$1.33B$1.25B$1.3B
Total Debt$269.87M$269.66M$331.42M$269.02M$323.23M$450.91M$451.26M$451.1M
Cash And Cash Equivalents$581.39M$570.39M$603.09M$550.94M$476.51M$397.53M$319.09M$304.96M
Total Liabilities$400.41M$469.47M$494.93M$462.32M$419.16M$618.75M$607.49M$609.9M
Total Stockholders Equity$1.14B$1.23B$1.34B$1.17B$1.01B$714.82M$646.91M$691.16M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio7.174.223.797.6212.1639.88—64.43
P/B ratio1.221.221.421.761.532.161.822.18
P/S ratio3.1———————
Debt To Equity0.240.220.250.230.320.630.70.65
Free Cash Flow Yield13.08%12.51%9.46%9.42%12.69%12.74%16.68%12.24%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio7.174.223.797.6212.1639.88—64.43
P/B ratio1.221.221.421.761.532.161.822.18
P/S ratio3.1———————
Return On Equity17.01%28.97%37.59%23.12%12.61%5.41%-9.23%3.38%
Debt To Equity0.240.220.250.230.320.630.70.65

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe7.49x
Pb1.21x
Revenue Growth Yoy-1.56%
EPS Growth Yoy-179.23%
Gross Margin73.90%
Operating Margin38.52%
ROE15.84%
ROIC9.87%
Debt To Equity0.24
FCF Yield13.41%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$19.03
Volume560,907
RSI (14)33.12
MACD-0.54
MACD signal-0.34
MACD histogram-0.2
ADX (14)21.62
SMA (50)$20.70
SMA (200)$21.89
ATR (14)$0.65
Historical volatility (annualized)38.01%
Volume (20-day average)862,137

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score74/100
Beta0.31
Annual volatility25.21%
Max Drawdown-22.19%
Sharpe Ratio-0.64
VaR (95%, 1-day)-2.45%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

INVA Financial Data FAQ

What is Innoviva, Inc.'s revenue?

Innoviva, Inc.'s revenue is one of the core financial data points for INVA. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Innoviva, Inc.'s revenue growing?

Revenue growth shows whether Innoviva, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is INVA's EPS?

INVA's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Innoviva, Inc.'s net income?

Innoviva, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Innoviva, Inc. generate?

Free cash flow shows how much cash Innoviva, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Innoviva, Inc. have?

Cash and debt help frame INVA's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.